Sokak İlaçları

Springer (2020) Modelling Drug Abuse Epidemics in the Presence of Limited Rehabilitation Capacity (30/11/2020 tarihinde https://link.springer.com/article/10.1007/s11538-016-0218-5 adresinden ulaşılmıştır)

Hawkins JD, Catalano RF, Miller JY. Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: implications for substance abuse prevention. Psychol Bull. 1992;112(1):64-105. doi:10.1037/0033-2909.112.1.64

HSGM (2019) Uyuşturucu Faaliyet Raporu 2018 (24/6/2020 tarihinde https://hsgm.saglik.gov.tr/depo/birimler/tutun-mucadele-bagimlilik-db/Uyusturucu/Uyusturucu_Faaliyet_Raporu_16.08.2019yeni.pdf adresinden ulaşılmıştır)

Palamar JJ, Kamboukos D. An Examination of Sociodemographic Correlates of Ecstasy Use Among High School Seniors in the United States. Subst Use Misuse. 2014;49(13):1774-1783. doi:10.3109/10826084.2014.926933

Bustamante D, Díaz-Véliz G, Paeile C, et al. Analgesic and behavioral effects of amphetamine enantiomers, p-methoxyamphetamine and n-alkyl-p-methoxyamphetamine derivatives. Pharmacology Biochemistry and Behavior. 2004;79(2):199-212. doi:10.1016/j.pbb.2004.06.017

Aspet (2020) Studies on Para-Methoxymethamphetamine (PMMA) Metabolite Pattern and Influence of CYP2D6 Genetics in Human Liver Microsomes and Authentic Samples from Fatal PMMA Intoxications | Drug Metabolism & Disposition. (20/11/2020 tarihinde https://dmd.aspetjournals.org/content/45/12/1326.long adresinden ulaşılmıştır)

Batisse A, Grégoire M, Marillier M, et al. [Cathinones use in Paris]. Encephale. 2016;42(4):354-360. doi:10.1016/j.encep.2015.09.002

Europeanreview (2018) Synthetic cathinones related fatalities: an update. European Review. (20/11/ 2020 tarinde https://www.europeanreview.org/article/14129 adresinden ulaşılmıştır)

Russo R, Marks N, Morris K, et al. Life-threatening Necrotizing Fasciitis Due to ‘Bath Salts’ Injection. ORTHOPEDICS. 2012;35(1):e124-e127. doi:10.3928/01477447-20111122-36

Researchgate (2018): Use and trade in the Middle East. (30/11/2020 tarihinde https://www.researchgate.net/publication/309372459_Captagon_Use_and_trade_in_the_Middle_East adresinden ulaşılmıştır)

Nature (2018) Insight of Captagon Abuse by Chemogenomics Knowledgebase-guided Systems Pharmacology Target Mapping Analyses | Scientific Reports. (30/11/2020. https://www.nature.com/articles/s41598-018-35449-6 adresinden ulaşılmıştır)

Kahn DE, Ferraro N, Benveniste RJ. 3 cases of primary intracranial hemorrhage associated with “Molly”, a purified form of 3,4-methylenedioxymethamphetamine (MDMA). Journal of the Neurological Sciences. 2012;323(1):257-260. doi:10.1016/j.jns.2012.08.031

BMJ (2014) Posterior spinal artery aneurysm rupture after ‘Ecstasy’ abuse | BMJ Case Reports. (20/11/2020 tarihinde https://casereports.bmj.com/content/2014/bcr-2014-011248.long adresinden ulaşılmıştır)

Tandf (2019) Full article: An update on the pharmacokinetic considerations in the treatment of ADHD with long-acting methylphenidate and amphetamine formulations (20/11/2020 tarihinde https://www.tandfonline.com/doi/full/10.1080/17425255.2019.1675636 adresinden ulaşılmıştır)

Shoptaw SJ, Kao U, Heinzerling K, et al. Treatment for amphetamine withdrawal. Cochrane Database Syst Rev. 2009;2009(2). doi:10.1002/14651858.CD003021.pub2

Gee P, Richardson S, Woltersdorf W, et al. Toxic effects of BZP-based herbal party pills in humans: a prospective study in Christchurch, New Zealand. The New Zealand medical journal. 2006;118:U1784.

ADLITIP (2005) Piperazin türevlerinin kötüye kullanımı (22/12/2020 tarihinde https://jag.journalagent.com/adlitip/pdfs/ADLITIP_21_3_31_38.pdf adresinden ulaşılmıştır)

Maurer HH, Kraemer T, Springer D, et al, Pharmacology, Toxicology, and Hepatic Metabolism of Designer Drugs of the Amphetamine (Ecstasy), Piperazine, and Pyrrolidinophenone Types: A Synopsis. Therapeutic Drug Monitoring. 2004;26(2):127-131.

Gee P, Gilbert M, Richardson S, et al. Toxicity from the recreational use of 1-benzylpiperazine. Clinical Toxicology. 2008;46(9):802-807. doi:10.1080/15563650802307602

Austin H, Monasterio E. Acute Psychosis Following Ingestion of ‘Rapture.’ Australas Psychiatry. 2004;12(4):406-408. doi:10.1080/j.1440-1665.2004.02137.x

Elie L, Baron M, Croxton R, et al. Microcrystalline identification of selected designer drugs. Forensic Science International. 2012;214(1):182-188. doi:10.1016/j.forsciint.2011.08.005

Arbo MD, Bastos ML, Carmo HF. Piperazine compounds as drugs of abuse. Drug and Alcohol Dependence. 2012;122(3):174-185. doi:10.1016/j.drugalcdep.2011.10.007

Libânio Osório Marta RF. Metabolism of lysergic acid diethylamide (LSD): an update. Drug Metab Rev. 2019;51(3):378-387. doi:10.1080/03602532.2019.1638931

Carhart-Harris RL, Kaelen M, Bolstridge M, et al. The paradoxical psychological effects of lysergic acid diethylamide (LSD). Psychol Med. 2016;46(7):1379-1390. doi:10.1017/S0033291715002901

Liechti ME. Modern Clinical Research on LSD. Neuropsychopharmacology.2017;42(11):2114-2127. doi:10.1038/npp.2017.86

Bertron JL, Seto M, Lindsley CW. DARK Classics in Chemical Neuroscience: Phencyclidine (PCP). ACS Chem Neurosci. 2018;9(10):2459-2474. doi:10.1021/acschemneuro.8b00266

NCBI (2019) Phencyclidine Toxicity - StatPearls - NCBI Bookshelf. (30/12/2020 tarihinde https://www.ncbi.nlm.nih.gov/books/NBK507865/ adresinden ulaşılmıştır)

Coffeen U, Pellicer F. Salvia divinorum: from recreational hallucinogenic use to analgesic and anti-inflammatory action. J Pain Res. 2019;12:1069-1076. doi:10.2147/JPR.S188619